ATC code C03
- 2 min read
- 6 chapters
Related on Lably
Through Medication
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC03. ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C03A Low-ceiling diuretics, thiazides
C03AA Thiazides, plain
- C03AA01 Bendroflumethiazide
- C03AA02 Hydroflumethiazide
- C03AA03 Hydrochlorothiazide
- C03AA04 Chlorothiazide
- C03AA05 Polythiazide
- C03AA06 Trichlormethiazide
- C03AA07 Cyclopenthiazide
- C03AA08 Methyclothiazide
- C03AA09 Cyclothiazide
- C03AA13 Mebutizide
- QC03AA56 Trichlormethiazide, combinations
C03AB Thiazides and potassium in combination
- C03AB01 Bendroflumethiazide and potassium
- C03AB02 Hydroflumethiazide and potassium
- C03AB03 Hydrochlorothiazide and potassium
- C03AB04 Chlorothiazide and potassium
- C03AB05 Polythiazide and potassium
- C03AB06 Trichlormethiazide and potassium
- C03AB07 Cyclopenthiazide and potassium
- C03AB08 Methyclothiazide and potassium
- C03AB09 Cyclothiazide and potassium
C03AH Thiazides, combinations with psycholeptics and/or analgesics
- C03AH01 Chlorothiazide, combinations
- C03AH02 Hydroflumethiazide, combinations
C03AX Thiazides, combinations with other drugs
- C03AX01 Hydrochlorothiazide, combinations
Sign in to keep reading
5 more chapters are free with a Lably account.
C03B Low-ceiling diuretics, excluding thiazides
C03BA Sulfonamides, plain
- C03BA02 Quinethazone
- C03BA03 Clopamide
- C03BA04 Chlortalidone
- C03BA05 Mefruside
- C03BA07 Clofenamide
- C03BA08 Metolazone
- C03BA09 Meticrane
- C03BA10 Xipamide
- C03BA11 Indapamide
- C03BA12 Clorexolone
- C03BA13 Fenquizone
- C03BA82 Clorexolone, combinations with psycholeptics
C03BB Sulfonamides and potassium in combination
- C03BB02 Quinethazone and potassium
- C03BB03 Clopamide and potassium
- C03BB04 Chlortalidone and potassium
- C03BB05 Mefruside and potassium
- C03BB07 Clofenamide and potassium
C03BC Mercurial diuretics
- C03BC01 Mersalyl
C03BD Xanthine derivatives
- C03BD01 Theobromine
C03BK Sulfonamides, combinations with other drugs
C03BX Other low-ceiling diuretics
- C03BX03 Cicletanine
C03C High-ceiling diuretics
C03CA Sulfonamides, plain
- C03CA01 Furosemide
- C03CA02 Bumetanide
- C03CA03 Piretanide
- C03CA04 Torasemide
C03CB Sulfonamides and potassium in combination
- C03CB01 Furosemide and potassium
- C03CB02 Bumetanide and potassium
C03CC Aryloxyacetic acid derivatives
- C03CC01 Etacrynic acid
- C03CC02 Tienilic acid
C03CD Pyrazolone derivatives
- C03CD01 Muzolimine
C03CX Other high-ceiling diuretics
- C03CX01 Etozolin
C03D Aldosterone antagonists and other potassium-sparing agents
C03DA Aldosterone antagonists
- C03DA01 Spironolactone
- C03DA02 Potassium canrenoate
- C03DA03 Canrenone
- C03DA04 Eplerenone
- C03DA05 Finerenone
C03DB Other potassium-sparing agents
- C03DB01 Amiloride
- C03DB02 Triamterene
C03E Diuretics and potassium-sparing agents in combination
C03EA Low-ceiling diuretics and potassium-sparing agents
- C03EA01 Hydrochlorothiazide and potassium-sparing agents
- C03EA02 Trichlormethiazide and potassium-sparing agents
- C03EA03 Epitizide and potassium-sparing agents
- C03EA04 Altizide and potassium-sparing agents
- C03EA05 Mebutizide and potassium-sparing agents
- C03EA06 Chlortalidone and potassium-sparing agents
- C03EA07 Cyclopenthiazide and potassium-sparing agents
- C03EA12 Metolazone and potassium-sparing agents
- C03EA13 Bendroflumethiazide and potassium-sparing agents
- C03EA14 Butizide and potassium-sparing agents
C03EB High-ceiling diuretics and potassium-sparing agents
- C03EB01 Furosemide and potassium-sparing agents
- C03EB02 Bumetanide and potassium-sparing agents
C03X Other diuretics
C03XA Vasopressin antagonists
- C03XA01 Tolvaptan
- C03XA02 Conivaptan
More in Health
Food and Drug AdministrationFederal agency of the United States Department of Health and Human ServicesCenters for Disease Control and PreventionUnited States government public health agencyNauseaMedical symptom or conditionSeizurePeriod of symptoms due to excessive or synchronous neuronal brain activityVomitingExpulsion of stomach contents via the mouth or noseIntravenous therapyMedication administered into a vein